203 related articles for article (PubMed ID: 35947558)
1. Chromatin accessibility of primary human cancers ties regional mutational processes and signatures with tissues of origin.
Ocsenas O; Reimand J
PLoS Comput Biol; 2022 Aug; 18(8):e1010393. PubMed ID: 35947558
[TBL] [Abstract][Full Text] [Related]
2. Regional mutational signature activities in cancer genomes.
Timmons C; Morris Q; Harrigan CF
PLoS Comput Biol; 2022 Dec; 18(12):e1010733. PubMed ID: 36469539
[TBL] [Abstract][Full Text] [Related]
3. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
[TBL] [Abstract][Full Text] [Related]
4. Cell-of-origin chromatin organization shapes the mutational landscape of cancer.
Polak P; Karlić R; Koren A; Thurman R; Sandstrom R; Lawrence M; Reynolds A; Rynes E; Vlahoviček K; Stamatoyannopoulos JA; Sunyaev SR
Nature; 2015 Feb; 518(7539):360-364. PubMed ID: 25693567
[TBL] [Abstract][Full Text] [Related]
5. Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes.
Lee CA; Abd-Rabbo D; Reimand J
Genome Biol; 2021 May; 22(1):133. PubMed ID: 33941236
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer analysis of whole genomes.
ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
[TBL] [Abstract][Full Text] [Related]
7. Cancer Mutational Processes Vary in Their Association with Replication Timing and Chromatin Accessibility.
Yaacov A; Vardi O; Blumenfeld B; Greenberg A; Massey DJ; Koren A; Adar S; Simon I; Rosenberg S
Cancer Res; 2021 Dec; 81(24):6106-6116. PubMed ID: 34702725
[TBL] [Abstract][Full Text] [Related]
8. The co-evolution of the genome and epigenome in colorectal cancer.
Heide T; Househam J; Cresswell GD; Spiteri I; Lynn C; Mossner M; Kimberley C; Fernandez-Mateos J; Chen B; Zapata L; James C; Barozzi I; Chkhaidze K; Nichol D; Gunasri V; Berner A; Schmidt M; Lakatos E; Baker AM; Costa H; Mitchinson M; Piazza R; Jansen M; Caravagna G; Ramazzotti D; Shibata D; Bridgewater J; Rodriguez-Justo M; Magnani L; Graham TA; Sottoriva A
Nature; 2022 Nov; 611(7937):733-743. PubMed ID: 36289335
[TBL] [Abstract][Full Text] [Related]
9. Decoding whole-genome mutational signatures in 37 human pan-cancers by denoising sparse autoencoder neural network.
Pei G; Hu R; Dai Y; Zhao Z; Jia P
Oncogene; 2020 Jul; 39(27):5031-5041. PubMed ID: 32528130
[TBL] [Abstract][Full Text] [Related]
10. Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis.
Petljak M; Alexandrov LB; Brammeld JS; Price S; Wedge DC; Grossmann S; Dawson KJ; Ju YS; Iorio F; Tubio JMC; Koh CC; Georgakopoulos-Soares I; Rodríguez-Martín B; Otlu B; O'Meara S; Butler AP; Menzies A; Bhosle SG; Raine K; Jones DR; Teague JW; Beal K; Latimer C; O'Neill L; Zamora J; Anderson E; Patel N; Maddison M; Ng BL; Graham J; Garnett MJ; McDermott U; Nik-Zainal S; Campbell PJ; Stratton MR
Cell; 2019 Mar; 176(6):1282-1294.e20. PubMed ID: 30849372
[TBL] [Abstract][Full Text] [Related]
11. Patterns and processes of somatic mutations in nine major cancers.
Jia P; Pao W; Zhao Z
BMC Med Genomics; 2014 Feb; 7():11. PubMed ID: 24552141
[TBL] [Abstract][Full Text] [Related]
12. Deep learning model accurately classifies metastatic tumors from primary tumors based on mutational signatures.
Zheng W; Pu M; Li X; Du Z; Jin S; Li X; Zhou J; Zhang Y
Sci Rep; 2023 May; 13(1):8752. PubMed ID: 37253775
[TBL] [Abstract][Full Text] [Related]
13. The landscape of cancer genes and mutational processes in breast cancer.
Stephens PJ; Tarpey PS; Davies H; Van Loo P; Greenman C; Wedge DC; Nik-Zainal S; Martin S; Varela I; Bignell GR; Yates LR; Papaemmanuil E; Beare D; Butler A; Cheverton A; Gamble J; Hinton J; Jia M; Jayakumar A; Jones D; Latimer C; Lau KW; McLaren S; McBride DJ; Menzies A; Mudie L; Raine K; Rad R; Chapman MS; Teague J; Easton D; Langerød A; ; Lee MT; Shen CY; Tee BT; Huimin BW; Broeks A; Vargas AC; Turashvili G; Martens J; Fatima A; Miron P; Chin SF; Thomas G; Boyault S; Mariani O; Lakhani SR; van de Vijver M; van 't Veer L; Foekens J; Desmedt C; Sotiriou C; Tutt A; Caldas C; Reis-Filho JS; Aparicio SA; Salomon AV; Børresen-Dale AL; Richardson AL; Campbell PJ; Futreal PA; Stratton MR
Nature; 2012 May; 486(7403):400-4. PubMed ID: 22722201
[TBL] [Abstract][Full Text] [Related]
14. Signatures of mutational processes in human cancer.
Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SA; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale AL; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DT; Jones D; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt AN; Valdés-Mas R; van Buuren MM; van 't Veer L; Vincent-Salomon A; Waddell N; Yates LR; ; ; ; ; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR
Nature; 2013 Aug; 500(7463):415-21. PubMed ID: 23945592
[TBL] [Abstract][Full Text] [Related]
15. Mutational signature SBS8 predominantly arises due to late replication errors in cancer.
Singh VK; Rastogi A; Hu X; Wang Y; De S
Commun Biol; 2020 Aug; 3(1):421. PubMed ID: 32747711
[TBL] [Abstract][Full Text] [Related]
16. Mutational signatures association with replication timing in normal cells reveals similarities and differences with matched cancer tissues.
Yaacov A; Rosenberg S; Simon I
Sci Rep; 2023 May; 13(1):7833. PubMed ID: 37188696
[TBL] [Abstract][Full Text] [Related]
17. A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes.
Youn A; Kim KI; Rabadan R; Tycko B; Shen Y; Wang S
BMC Med Genomics; 2018 Nov; 11(1):98. PubMed ID: 30400878
[TBL] [Abstract][Full Text] [Related]
18. The shaping of cancer genomes with the regional impact of mutation processes.
Lee SY; Wang H; Cho HJ; Xi R; Kim TM
Exp Mol Med; 2022 Jul; 54(7):1049-1060. PubMed ID: 35902761
[TBL] [Abstract][Full Text] [Related]
19. The repertoire of mutational signatures in human cancer.
Alexandrov LB; Kim J; Haradhvala NJ; Huang MN; Tian Ng AW; Wu Y; Boot A; Covington KR; Gordenin DA; Bergstrom EN; Islam SMA; Lopez-Bigas N; Klimczak LJ; McPherson JR; Morganella S; Sabarinathan R; Wheeler DA; Mustonen V; ; Getz G; Rozen SG; Stratton MR;
Nature; 2020 Feb; 578(7793):94-101. PubMed ID: 32025018
[TBL] [Abstract][Full Text] [Related]
20. A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.
Bertl J; Guo Q; Juul M; Besenbacher S; Nielsen MM; Hornshøj H; Pedersen JS; Hobolth A
BMC Bioinformatics; 2018 Apr; 19(1):147. PubMed ID: 29673314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
